INMUNE BIO INC. (INMB) Debt Components
- 2025-06-30: Long-term Debt, Current MaturitiesUSD (m); Secured DebtUSD (m); Long-term DebtUSD $15.00M; Long-term Debt and Lease Obligation, CurrentUSD (m).
- 2025-03-31: Long-term Debt, Current MaturitiesUSD (m); Secured DebtUSD (m); Long-term DebtUSD $15.00M; Long-term Debt and Lease Obligation, CurrentUSD (m).
- 2024-12-31: Long-term Debt, Current MaturitiesUSD (m); Secured DebtUSD (m); Long-term DebtUSD $15.00M; Long-term Debt and Lease Obligation, CurrentUSD (m).
- 2024-09-30: Long-term Debt, Current MaturitiesUSD $2.49M; Secured DebtUSD $2.50M; Long-term DebtUSD (m); Long-term Debt and Lease Obligation, CurrentUSD (m).
INMUNE BIO INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Secured Debt USD | Long-term Debt USD | Long-term Debt and Lease Obligation, Current USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt, Gross USD | Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed pure | Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two USD | Long-term Debt, Maturities, Repayments of Principal in Rolling Year Three USD | Long-term Debt, Maturities, Repayments of Principal in Rolling Year Four USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | (m) | (m) | $15.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | $15.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $15.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $2.49M | $2.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $4.98M | $5.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $7.46M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $45.00K |
| 2023-12-31 | $9.92M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | $10.00M | (m) | (m) | (m) | (m) | $79.00K |
| 2023-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · 1.00% | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | (m) | $12.50M | $430.00K | (m) | (m) | (m) | $2.50M | $10.00M | (m) | $124.00K |
| 2023-06-30 | (m) | (m) | $15.00M | $463.00K | (m) | (m) | (m) | (m) | $5.00M | $10.00M | $178.00K |
| 2023-03-31 | (m) | (m) | $15.00M | (m) | (m) | (m) | (m) | (m) | $5.00M | $10.00M | (m) |
| 2022-12-31 | $5.00M | (m) | (m) | (m) | $9.70M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | $526.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | $15.00M | (m) | (m) | (m) | (m) | (m) | $5.00M | $10.00M | $303.00K |
| 2022-09-30 | (m) | (m) | $15.00M | $607.00K | (m) | (m) | (m) | (m) | $5.83M | $9.17M | $371.00K |
| 2022-06-30 | (m) | (m) | $15.00M | $645.00K | (m) | (m) | (m) | (m) | $5.83M | $9.17M | $429.00K |
| 2022-03-31 | (m) | (m) | $15.00M | $684.00K | (m) | (m) | (m) | (m) | $5.83M | $9.17M | $486.00K |
| 2021-12-31 | (m) | (m) | $15.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | $704.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $5.83M | $9.17M | $542.00K |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.77M | (m) | (m) | (m) |
| 2021-09-30 | (m) | (m) | $15.00M | (m) | (m) | (m) | (m) | (m) | $5.83M | $9.17M | $599.00K |
| 2021-06-30 | (m) | (m) | (m) | (m) | $14.35M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-10 | (m) | (m) | $15.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | $160.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |